0001682873-19-000002.txt : 20190103
0001682873-19-000002.hdr.sgml : 20190103
20190103130904
ACCESSION NUMBER: 0001682873-19-000002
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20181221
FILED AS OF DATE: 20190103
DATE AS OF CHANGE: 20190103
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Danielsen Erik
CENTRAL INDEX KEY: 0001682873
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-12033
FILM NUMBER: 19504528
MAIL ADDRESS:
STREET 1: 9900 CAVENDISH BLVD
CITY: ST LAURENT
STATE: A8
ZIP: H4M 2V2
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: NYMOX PHARMACEUTICAL CORP
CENTRAL INDEX KEY: 0001018735
STANDARD INDUSTRIAL CLASSIFICATION: IN VITRO & IN VIVO DIAGNOSTIC SUBSTANCES [2835]
IRS NUMBER: 000000000
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 9900 CAVENDISH BLVD., SUITE 306
STREET 2: ST. LAURENT
CITY: QUEBEC CANADA
STATE: A8
ZIP: H4M 2V2
BUSINESS PHONE: 1-800-936-9669
MAIL ADDRESS:
STREET 1: 9900 CAVENDISH BLVD., SUITE 306
STREET 2: ST. LAURENT
CITY: QUEBEC CANADA
STATE: A8
ZIP: H4M 2V2
4
1
primary_doc.xml
PRIMARY DOCUMENT
X0306
4
2018-12-21
0
0001018735
NYMOX PHARMACEUTICAL CORP
NYMX
0001682873
Danielsen Erik
9900 CAVENDISH BLVD
ST LAURENT
A8
H4M 2V2
QUEBEC, CANADA
0
1
0
0
CFO
common stock
2018-12-21
4
P
0
6000
1.3475
A
20900
D
Erick Danielsen
2019-01-03